| Synonyms: | |
| Status: | Phase 1 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | PX47LB88FO |
| InChI Key | ROFVXGGUISEHAM-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C20H22N2O3 |
| Molecular Weight | 338.41 |
| AlogP | 3.87 |
| Hydrogen Bond Acceptor | 3.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 4.0 |
| Polar Surface Area | 81.42 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 25.0 |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Hydrolase
|
- | 1-240 | - | 1 | 8-100 | |
|
Enzyme
Protease
Serine protease
Serine protease SC clan
Serine protease S33 family
|
- | 1100 | - | - | - | |
|
Ion channel
Voltage-gated ion channel
Transient receptor potential channel
|
100-24500 | - | - | - | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Schizophrenia | 1 | D012559 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL184238 |
| EPA CompTox | DTXSID70203046 |
| FDA SRS | PX47LB88FO |
| Guide to Pharmacology | 4339 |
| PubChem | 1383884 |
| SureChEMBL | SCHEMBL93842 |
| ZINC | ZINC000001238258 |